Can Increasing the Viscosity of Formulations be used to Reduce the Human Skin Penetration of the Sunscreen Oxybenzone?  by Cross, Sheree E. et al.
COMMUNICATIONS
Can Increasing the Viscosity of Formulations be used to
Reduce the Human Skin Penetration of the Sunscreen
Oxybenzone?
Sheree E. Cross, Ruoying Jiang,* Heather A. E. Benson,² and Michael S. Roberts
Department of Medicine, University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland, Australia; *School of Pharmacy, University of
Queensland, Brisbane, Queensland, Australia; ²Western Australian Biomedical Research Institute and School of Biomedical Sciences, Curtin University
of Technology, Perth, Western Australia
The effect of adding thickening agents on the pene-
tration of a sunscreen benzophenone-3 through epi-
dermal and a high-density polyethylene membrane
was studied using both very thick (in®nite dose) and
thin (in use) applications. Contradictory results were
obtained. Thickening agents retard skin penetration,
in a manner consistent with a diffusional resistance
in the formulation, when applied as an in®nite dose.
In contrast, when applied as in thin (in use) doses,
thickening agents promote penetration, most likely
through greater stratum corneum diffusivity arising
from an enhanced hydration by the thicker formula-
tions. The two key implications from this work are
(i) a recognition of the danger in the potential extra-
polation of in®nite dosing to in use situations, and
(ii) to recognize that thicker formulations may
sometimes enhance the penetration of other topical
agents when applied ``in use''. Key words: epidermis/
®nite dosing/hydration/in®nite dosing. J Invest Dermatol
117:147±150, 2001
T
he increased awareness of protection against skin
cancer has led to a rise in the use of topically applied
chemical sunscreen agents. The desirable site of
action of these chemicals is restricted to the skin
surface or within only the upper most layers of the
stratum corneum. It has been demonstrated, however, that the skin
penetration and retention of sunscreen agents from commercial
products can differ signi®cantly between the formulations used
(Jiang et al, 1998). Sunscreens formulated as emulsions, dispersions
of one immiscible liquid in another in the form of tiny droplets
formed and stabilized by an emulsi®er, are the most common
topical commercial ultraviolet protectant products. In a recent
clinical study up to 2% of an applied dose of the sunscreen agent
oxybenzone (benzophenone-3, BP), including metabolites, was
found to be excreted in the urine of volunteers applying a
commercial emulsion formulation (Hayden et al, 1997).
One approach used to ensure a more controlled application of
products, and the production of a uniform, thick, and effective
sunscreen ®lm on the skin, is to increase the viscosity of emulsion
formulations. There are relatively few studies examining the effect
of vehicle viscosity on cutaneous penetration following the
application of ®nite or small ``in use'' doses of topical drug
formulations. Tsai et al (1999) showed that the penetration of the
alkaloid berberine through rat skin in vitro was inversely related to
applied ointment viscosity. Potter et al (1999) recently showed that
both the uptake of radiolabeled benzo[a]pyrene from topically
applied oils into the blood and binding of metabolites to skin DNA
was signi®cantly less when the oil viscosity was higher. In this study
we sought to determine whether increasing the viscosity of an
emulsion formulation could also be used to retard the cutaneous
penetration of sunscreens, using BP as a prototype. We sought to
determine and compare the effect of viscosity on the in vitro
penetration of BP from four different types of emulsion formula-
tions, at the same thermodynamic activity, through both epidermal
and high-density polyethylene (HDPE) membranes, allowing us to
control for any possible vehicle±skin interactions. In addition, we
examined the change in percutaneous penetration and retention
kinetics of BP from the emulsions following in®nite and ®nite dose
application in an attempt to de®ne the effects of viscosity on actual
``in use'' conditions (where factors such as formulation evaporation,
estimated from the rate of vehicle water loss, would be expected to
have a signi®cant contribution to release kinetics).
GENERAL MATERIALS AND INSTRUMENTATION
Materials BP and bovine serum albumin (fraction V) were
supplied by Sigma-Aldrich Chemical Co. (Sydney, NSW,
Australia). Other reagents included coconut oil (The Oil Garden,
Brisbane, Australia), Tego care 450 (TH Goldschmidt AG, Essen,
Germany), cetomacrogol emulsifying wax BP (David Craig and
Co, Brisbane, Australia), and carbomer 940 (BF Goodridge, Avon
Lake, Ohio). HDPE 20 mm membrane was donated by Beaver
Plastics (QLD) Pty Ltd (Coopers Plains, QLD, Australia). High
performance liquid chromatography grade methanol was used for
high performance liquid chromatography analysis and all other
chemicals used in the study were of analytical grade.
High performance liquid chromatography instrument-
ation This method has been described in detail elsewhere
(Jiang et al, 1996).
METHODS
Preparation of emulsions Two oil-in-water emulsions were prepared
using a conventional emulsi®er (cetomacrogol emulsifying wax) or a new
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lipid emulsi®er (Tego care 450). A summary of the ®nal composition of
the emulsions used in the study is shown in Table I. Brie¯y, the oil
phase (containing BP, ®nal concentration 2% equating to 50% of its
solubility, and the emulsi®er) and the water phase were heated separately
to 75°C and mixed together until cooled to room temperature. Sodium
hydroxide (2 M) was the neutralization agent for the carbomer to give a
pH for the ®nal product of 6. Higher viscosity emulsions were prepared
by the addition of Carbomer 940 to the aqueous phase of cetomacrogol
emulsions before heating and mixing, to give a ®nal concentration in the
formulation of 0.2 or 0.5%.
Viscosity The comparative viscosity of emulsions was determined at a
shear rate of 0.3 r.p.m. using a Brook®eld viscometer (Brook®eld
Engineering Labs Inc., Stoughton, MA).
Formulation evaporation rate An estimation of the relative
evaporation rates of water from each of the emulsions applied as a ®lm
to the forearm skin of a human volunteer were made using a trans-
epidermal water loss (TEWL) meter (Tewameter 210, Courage and
Khazaka Electronic GmbH, Cologne, Germany). Baseline TEWL
readings were made on untreated forearm skin and an even ®lm of each
emulsion applied to separate areas and spread to identical thickness using
a glass slide. TEWL readings were then taken over the application site
until no further signi®cant changes in water loss were noticed. Plots of
TEWL (g per h per m2) vs time (min) were plotted and slopes of the
exponential decay curves ®tted to the data used as an index of relative
evaporation rate.
Membrane diffusion studies Human epidermal tissue (female
abdominal) from cosmetic surgery was obtained by heat separation
(Kligman and Christophers, 1963). After blunt dissection of the full-
thickness skin, resultant epidermis was air dried and stored at ±20°C until
use. Epidermis was thawed at room temperature and HDPE membranes
cleaned with distilled water before mounting between the donor and
receptor chambers of horizontal Franz-type diffusion cells. The area
available for diffusion was approximately 1.2 cm2 and the receptor
chamber volume approximately 3.4 ml. The receptor chambers were
®lled with 4% bovine serum albumin in phosphate-buffered saline,
pH 7.4. Diffusion cells were equilibrated at 37°C 6 0.1°C for at least
1 h prior to application of the BP emulsions. Aliquots, 1 ml of emulsions
for in®nite dose studies and 3±4 mg per cm2 for the ®nite dose study,
were introduced into the donor chambers at t = 0. The receptor ¯uids
were stirred throughout with magnetic ¯eas and samples (0.1 ml) were
taken from the receptor chamber periodically (up to 6 h). Six replicates
were used for the epidermis and four for the HDPE membrane. At the
end of the diffusion studies, remaining solution in each donor chamber
was wiped out using soft tissue and the membranes cleaned with tissue
and distilled water. BP remaining within the membrane (mg) was
determined by methanol extraction (recovery > 99%) with quantitation
by high performance liquid chromatography. The ¯ux of BP through
the membranes into the receptor ¯uid from each of the emulsions was
determined from slopes of plots of cumulative concentration in the
receptor phase vs time and expressed as mg per h per cm2. For ®nite
doses, epidermal ¯uxes were estimated from the initial sections of the
concentration±time plots before the pro®les plateaued due to depletion
of dose.
RESULTS
Figure 1 shows the human epidermal ¯ux and membrane
retention for BP vs the viscosity of the formulations used. It is
apparent that while the ¯ux decreases with formulation viscosity for
the very thick (in®nite dose) formulation, the ¯ux was increased
over the control formulation with increasing viscosity for the very
thin (®nite or ``in use'' dose) (Fig 1A). The epidermal membrane
retention also decreases with viscosity for the in®nite dose
(Fig 1B). In contrast, the epidermal membrane retention for the
®nite dose appears to be unaffected by the viscosity of the
formulation used.
Table I. Composition of the BP o/w emulsion
formulations used in the study
Ingredient
Cream 1
%
Cream 2
%
Cream 3
%
Cream 4
%
Coconut oil 30 30 30 30
BPa 2 2 2 2
Cetomacrogol
emulsifying
wax
5 0 5 5
Tego care 450 0 5 0 0
Carbomer 940 0 0 0.2 0.5
Water qs to 100 qs to 100 qs to 100 qs to 100
aConcentration at 50% of its solubility in the coconut oil phase.
Figure 1. Epidermal ¯ux and retention of BP. Relationships
observed between (A) estimated human epidermal ¯ux and (B) human
epidermal retention and formulation viscosity (dark columns = in®nite
dosing; light columns = ®nite dosing), mean 6 SD, n = 6.
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The human epidermal ¯uxes, membrane retention, and
viscosities determined for each formulation used are shown in
Table II. It is apparent that the viscosity of creams formulated with
Tego care 450 emulsi®er was higher than with Cetomacrogol wax
and was further increased by adding carbomer 940. Also shown in
Table II are the evaporation indices for each formulation,
determined from the slopes of the exponential decay in evaporation
rate for each formulation. This evaporation rate was highly
correlated with the reciprocal of the formulation viscosity
(r2 = 0.993, p < 0.01). Also shown in Table II are the ¯ux and
membrane retention for BP when applied as an in®nite dose. The
penetration and retention pro®les with viscosity are similar to that
observed for human epidermal membranes.
DISCUSSION
This work suggests that the inclusion of thickening agents in topical
formulations may have apparent contradictory effects on the skin
penetration of the sunscreen agent BP when assessed using ®nite
(``in use'') and in®nite (very thick application) dosing regimens.
This effect was apparent for both human epidermal and plastic
(HDPE) membranes. Concerns about using the more widely
reported in®nite dosing studies to represent ``in use'' membranes
was raised in this journal more than two decades ago (Franz, 1978).
Interestingly, our study emphasizes this concern in showing that
whereas adding a thickening agent may decrease skin penetration
when an in®nite dose is applied, it actually facilitates penetration
over control values for a ®nite dose.
The discrepancy in the in®nite and ®nite dosing results are likely
to arise from the differing diffusion of BP in the formulations and
skin hydration arising in the two situations (Fig 2). In the ®nite
(``in use'') case, the residual ®lm is unlikely to exert any signi®cant
resistance to penetration relative to the epidermal membrane
barrier. Slower water evaporation, consistent with the water
evaporation index (Table II), is likely to result in a higher water
content in the residual ®lm and an increase in skin penetration due
to a higher diffusivity in a more hydrated membrane (Roberts and
Walker, 1993). It is unlikely that the formulations have affected
partitioning into the skin as epidermal retention for the four
vehicles was similar (Table II). Cross and Roberts (2000) have
recently shown that occlusion can cause signi®cant increases in the
diffusivity of solutes through an epidermal membrane depending
on the type of vehicle occluded.
In contrast, solute diffusion through the formulation will become
a signi®cant resistance in the penetration process, and if the
formulation is very thick (as in the in®nite case) diffusion in the
formulation becomes an even greater determinant of transport than
epidermal membrane ¯ux. Hence, as shown in Table II, the ¯ux
of BP through both human epidermal and plastic (HDPE)
membranes decreases with increasing formulation viscosity. In
this context, both macroviscosity and microviscosity contribute to
the overall viscosity (Di Colo et al, 1980). Consistent with a
formulation diffusion resistance limitation, Table II also shows that
the membrane retention of BP in both membranes is lowest for the
formulation with the highest viscosity. When the epidermal ¯ux is
Table II. Physical properties and BP membrane penetration and retention characteristics for each of the emulsion
formulations studied
Parameter
Cream 1
control
Cream 2
Tego care 450
Cream 3
0.2% Carbomer
Cream 4
0.5% Carbomer
Viscosity (cps) 68,000 180,000 430,000 1,600,000
Evaporation index* 0.249 0.165 0.148 0.127
Flux (mg per h per cm2) 6 SD
HDPEÐin®nite 8.5 6 2.1 8.0 6 0.7 6.6 6 0.7 3.7 6 0.9
EpidermisÐin®nite 3.3 6 0.8 2.1 6 0.5 1.0 6 0.5 0.3 6 0.01
EpidermisÐ®nite 0.18 6 0.01 0.32 6 0.09 0.28 6 0.02 0.33 6 0.01
Membrane retention (mg) 6 SD
HDPEÐin®nite 4.7 6 0.9 3.8 6 0.5 2.3 6 0.3 1.7 6 0.2
EpidermisÐin®nite 27.0 6 4.4 18.4 6 0.6 13.1 6 0.8 5.0 6 4.5
EpidermisÐ®nite 9.8 6 2.5 13.2 6 1.7 10.3 6 2.1 9.0 6 2.4
aExponential decay coef®cient ®tted to TEWL (g per h per m2) vs time (min) plots.
Figure 2. Contradictory effects of increasing
the thickness of formulations on BP pene-
tration through epidermal membranes using
in®nite and ®nite topical dosing. (A) In®nite
does, thick formulation; (B) ®nite dose, thin ``in
use'' formulation.
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formulation diffusion controlled, the concentration at the absorp-
tion site into the skin will be lowest in the formulation showing the
least BP diffusivity, i.e., the highest viscosity product and this
lowest concentration is then in turn re¯ected by the lowest
membrane retention for this formulation. It is possible that, in
contrast to the ®nite dose formulations where the site of sunscreen
action is in the upper layers of the stratum corneum, within the
thicker layers of in®nite dose formulations could be the site of
action for these products.
The clinical implication from this study is that caution should be
exercised in assuming that thicker formulations applied to the skin
may retard the penetration of topically applied substances such as
sunscreens. This work has shown that, whereas indeed thicker
formulations impede the skin penetration of BP under in®nite
dosing conditions, thicker formulations may lead to faster skin
penetration using thin, ``in use'' formulations. Further, this study
highlights the dangers of trying to extrapolate in®nite dose skin
penetration data to ®nite, ``in use'' situations.
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